| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024334 Immunotherapeutic methods and systems |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | CA2575683A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 02/02/2006 | CA2573768A1 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/26/2006 | WO2006009975A2 Histamine to treat disorders affecting muscle function |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060018844 Botulinum toxin dental therapy for angular cheilosis |
| 01/26/2006 | CA2574135A1 Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
| 01/25/2006 | EP1619249A1 Induction of exon skipping in eukaryotic cells |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618881A1 Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
| 01/25/2006 | EP1617862A2 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1490363B1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/24/2006 | US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060013897 Compositions for cancer therapy saponins or sapogenins |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | CA2475174A1 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 01/18/2006 | EP1615896A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723277A Culture medium composition, culture method, and myoblasts obtained, and their uses |
| 01/18/2006 | CN1723015A Fatigue reducing agent |
| 01/18/2006 | CN1720948A Dripping pills of lllicium henryi dripping pills and method for preparing the same |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236809C Trauma treating medicament and method for making same |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | CN1719984A Sustained improver of muscular fatigue |
| 01/11/2006 | CN1718194A Oligonucleotide medicine for treating myophagism |
| 01/11/2006 | CN1718190A Nux vomica alkaloid liposome, and its prepn. method |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984624 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 01/10/2006 | US6984405 Compositions for inducing secretion of insulin-like growth factor-1 |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003988 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003986 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060002983 Muscle building preparation |
| 01/05/2006 | US20060002937 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/04/2006 | EP1611901A1 Preventive or remedy for teeth grinding |
| 01/04/2006 | EP1611144A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| 01/04/2006 | EP1610785A2 Pharmaceutical combination for the treatment of spasticity and/or pain |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1494658B1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1189886B1 Ethanesulfonyl-piperidine derivatives |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234358C Benzothiazole derivatives |
| 01/03/2006 | US6982274 excellent inhibitory action on protein phosphatase (protein kinase), especially on JNK protein kinase; therapeutic or prophylactic agents for immunologic disease, inflammatory disease and/or neurodegenerative disease |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |